GLP-1R rs6923761 was strongly correlated with fasting serum GLP-1 levels in patients with initial T2DM; specific variants were related to weight loss outcomes [18], as well as the efficacy of liraglutide, a GLP-1 receptor agonist [19]. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.